2024
Physiological Assessment with iFR prior to FFR Measurement in Left Main Disease
Warisawa T, Cook C, Ahmad Y, Howard J, Seligman H, Rajkumar C, Toya T, Doi S, Nakajima A, Nakayama M, Vera-Urquiza R, Yuasa S, Sato T, Kikuta Y, Kawase Y, Nishina H, Al-Lamee R, Sen S, Lerman A, Matsuo H, Akashi Y, Escaned J, Davies J. Physiological Assessment with iFR prior to FFR Measurement in Left Main Disease. Cardiovascular Intervention And Therapeutics 2024, 39: 241-251. PMID: 38642290, PMCID: PMC11164744, DOI: 10.1007/s12928-024-00989-4.Peer-Reviewed Original ResearchMajor adverse cardiovascular eventsArea under the curveFractional flow reserveLeft main diseaseOptimal cut-off valueInstantaneous wave-free ratioAdverse cardiovascular eventsClinical outcomesCardiovascular eventsRevascularization decision-makingFlow reserveMain diseaseClinical outcomes of patientsPhysiological assessmentPrediction of MACEPrediction of adverse cardiovascular eventsFractional flow reserve measurementsInternational multicenter registryReceiver-operating characteristic analysisOutcomes of patientsLeft main coronary artery diseasePrediction of cardiovascular eventsComposite of deathNon-fatal myocardial infarctionIschemia-driven target lesion revascularization
2023
Physiology-guided PCI versus CABG for left main coronary artery disease: insights from the DEFINE-LM registry
Warisawa T, Cook C, Kawase Y, Howard J, Ahmad Y, Seligman H, Rajkumar C, Toya T, Doi S, Nakajima A, Tanigaki T, Omori H, Nakayama M, Vera-Urquiza R, Yuasa S, Sato T, Kikuta Y, Nishina H, Al-Lamee R, Sen S, Lerman A, Akashi Y, Escaned J, Matsuo H, Davies J. Physiology-guided PCI versus CABG for left main coronary artery disease: insights from the DEFINE-LM registry. Cardiovascular Intervention And Therapeutics 2023, 38: 287-298. PMID: 37017899, PMCID: PMC10247826, DOI: 10.1007/s12928-023-00932-z.Peer-Reviewed Original ResearchConceptsUnprotected left main coronary diseasePercutaneous coronary interventionInstantaneous wave-free ratioMain coronary artery diseaseNon-fatal myocardial infarctionCoronary artery bypassCoronary artery diseasePrimary endpointCause deathLesion revascularizationArtery bypassSYNTAX scoreCoronary interventionArtery diseaseClinical outcomesMyocardial infarctionIschemia-driven target lesion revascularizationLeft main coronary artery diseaseArt percutaneous coronary interventionLeft main coronary diseaseLower cardiovascular event ratesMajor adverse cardiovascular eventsLong-term clinical outcomesPropensity scorePhysiology-guided percutaneous coronary intervention
2022
MEDICAL THERAPY VS. REVASCULARIZATION IN LEFT MAIN CORONARY ARTERY DISEASE WITH PROVEN ISCHEMIA: INSIGHTS FROM THE DEFINE-LM REGISTRY
Warisawa T, Cook C, Kawase Y, Howard J, Nakayama M, Ahmad Y, Seligman H, Rajkumar C, Doi S, Nakajima A, Goto S, Vera-Urquiza R, Kikuta Y, Lerman A, Akashi Y, Escaned J, Matsuo H, Davies J. MEDICAL THERAPY VS. REVASCULARIZATION IN LEFT MAIN CORONARY ARTERY DISEASE WITH PROVEN ISCHEMIA: INSIGHTS FROM THE DEFINE-LM REGISTRY. Journal Of The American College Of Cardiology 2022, 79: 586. DOI: 10.1016/s0735-1097(22)01577-7.Peer-Reviewed Original ResearchLeft main coronary artery diseaseMain coronary artery diseaseCoronary artery diseaseArtery diseaseRevascularizationIschemiaRegistryDisease
2020
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials
Ahmad Y, Howard JP, Arnold AD, Cook CM, Prasad M, Ali ZA, Parikh MA, Kosmidou I, Francis DP, Moses JW, Leon MB, Kirtane AJ, Stone GW, Karmpaliotis D. Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials. European Heart Journal 2020, 41: 3228-3235. PMID: 32118272, PMCID: PMC7557472, DOI: 10.1093/eurheartj/ehaa135.Peer-Reviewed Original ResearchConceptsCoronary artery bypass graft surgeryPercutaneous coronary interventionDrug-eluting stentsMain coronary artery diseaseCoronary artery diseaseMyocardial infarctionCardiac deathUnplanned revascularizationCause mortalityCoronary interventionArtery diseaseLeft main coronary artery diseaseRandomized clinical trial evidenceSimilar long-term mortalityArtery bypass graft surgerySignificant differencesUnplanned revascularization proceduresWeighted mean followBypass graft surgeryCoronary artery bypassPrimary efficacy endpointClinical trial evidenceLong-term mortalityRisk of strokeGold standard therapyCOMPARISON OF INTRAVASCULAR ULTRASOUND-DERIVED MINIMUM LUMEN AREA AND INSTANTANEOUS WAVE-FREE RATIO IN LEFT MAIN CORONARY ARTERY DISEASE
Lerman A, Toya T, Hajj S, Warisawa T, Nan J, Cook C, Rajkumar C, Howard J, Seligman H, Ahmad Y, Doi S, Nakajima A, Nakayama M, Goto S, Vera-Urquiza R, Sato T, Kikuta Y, Kawase Y, Nishina H, Nakamura S, Matsuo H, Escaned J, Akashi Y, Davies J. COMPARISON OF INTRAVASCULAR ULTRASOUND-DERIVED MINIMUM LUMEN AREA AND INSTANTANEOUS WAVE-FREE RATIO IN LEFT MAIN CORONARY ARTERY DISEASE. Journal Of The American College Of Cardiology 2020, 75: 1392. DOI: 10.1016/s0735-1097(20)32019-2.Peer-Reviewed Original Research